MedTrace Logo

Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients

NCT01002105 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2017-01-27

Study results available
· View outcomes & findings →

Summary

This is a study of Baclofen as an add-on to standard treatment for alcohol-dependent patients.

Conditions

  • Alcohol Dependence

Interventions

DRUG

Baclofen

Baclofen 50mg per day for 12 weeks and psychosocial intervention

OTHER

Control group

psychosocial intervention and placebo for 12 weeks

Sponsors & Collaborators

  • Ministry of Health, Israel

    collaborator OTHER_GOV

  • Sha'ar Menashe Mental Health Center

    lead OTHER

Principal Investigators

  • Alexander M Ponizovsky, MD, PhD · Ministry of health, State of Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-05-31
Completion
2012-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01002105 on ClinicalTrials.gov